News
Waters Corporation Appoints Wei Jiang to Board of Directors
Waters Corporation (NYSE: WAT) today announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President
Pfizer Declares Third-Quarter 2021 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a 39-cent third-quarter 2021 dividend on the company’s common stock, payable September 7, 2021, to holders of the Common
Humana Expanding its Commitment to Improving Physical and Mental Health Across North Carolina
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced it is expanding its commitment to the health and well-being of North Carolinians by more than doubling the number of
First Participant Dosed in Pfizer’s Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib and Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in TALAPRO-3, a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial. The study will
Endurance Athlete Sébastien Sasseville to Ride Across Canada in Support of JDRF’s Access For All Campaign
Dexcom, Inc. and Tandem Diabetes Care, Inc. are thrilled to announce their support of Sébastien Sasseville, a Canadian endurance athlete and person living with type 1 diabetes, as he attempts to
Agilent Completes the InfinityLab Bio LC Portfolio
Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry. The release is central to the
Humana Pharmacy Moves to Sustainable Packaging for Temperature-Sensitive Shipments
Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced that Humana Pharmacy customers have started receiving temperature-sensitive medications in new
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Pfizer Inc. (NYSE: PFE) and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive
Pfizer Invites Public to View and Listen to Webcast of Pfizer July 28 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, July 28, 2021. The
CenterWell Senior Primary Care to Open Four Senior-Focused Care Centers in South Louisiana
CenterWell Senior Primary Care will open four new senior-focused care centers in South Louisiana by early 2022, giving seniors in Denham Springs, Hammond, Covington, Slidell and surrounding areas
West Virginia PEIA Renews Humana as Health Insurer for Retirees
Humana Inc. (NYSE: HUM) has been awarded a new, four-year contract with the West Virginia Public Employee’s Insurance Agency (PEIA). As part of the contract, effective Jan. 1, 2022, Humana will
Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results
Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ Premier System, the first liquid chromatography system optimized for chromatographic separations on 2.5 – 3.5 micron columns to also
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and
Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy
Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are on intensive insulin therapy, age two years or older, may
Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021
Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at
League and Humana Partner to Digitally Transform Healthcare Experience for Millions of Members
League, a technology-focused health company powering digital transformation in healthcare, and Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced an agreement to
Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200
CenterWell Senior Primary Care to Open Six Senior-Focused Care Centers in Atlanta
CenterWell Senior Primary Care will open six new senior-focused primary care centers in metro Atlanta through 2022, marking the company’s debut in the Atlanta market, giving local seniors access to
Humana Names Carolyn Tandy Chief Inclusion and Diversity Officer
Leading health and well-being company Humana Inc. (NYSE: HUM) has named Carolyn Tandy to the position of Senior Vice President and Chief Inclusion and Diversity Officer. Tandy will be responsible
U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease
Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced
Dexcom richtet den Blick auf die Zukunft der kontinuierlichen Blutzuckermessung
DexCom, Inc. (Nasdaq: DXCM), der Weltmarktführer im Bereich der kontinuierlichen Blutzuckermessung in Echtzeit für Menschen mit Diabetes, hat heute während der 14. Internationalen Konferenz über
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO)
Dexcom Looks to the Future of Continuous Glucose Monitoring
DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the publication and presentation of two new studies during the 14